TY  - GEN
AU  - De Souza,C A
AU  - Santini,G
AU  - Marino,G
AU  - Nati,S
AU  - Congiu,A M
AU  - Vigorito,A C
AU  - Damasio,E
TI  - Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study
SN  - 0100-879X
PY  - 2000///0828
KW  - Adolescent
KW  - Adult
KW  - Amifostine
KW  - adverse effects
KW  - Antineoplastic Agents, Alkylating
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Cytoprotection
KW  - drug effects
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Radiation-Protective Agents
KW  - Statistics, Nonparametric
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1590/s0100-879x2000000700009
ER  -